Nonclinical Drug Development from lead optimization to IND and Marketing Applications. Both small molecule drugs and protein biotherapeutics. Toxicology/Pharmacology/PK/ADME. US, EU and Japanese regulatory submissions.
Experience
Therapeutic areas of experience: Alzheimer's disease, Parkinson's disease, pain, migraine, oncology, diabetes, epilepsy, stroke, rheumatoid arthritis, inflammatory bowel disease, sepsis. Drug classes: small molecule receptor inhibitors, enzyme inhibitors, and ion channel blockers; anti-angiogenesis factors, growth factors, monoclonal antibodies, proteins, and polyethylene glycol conjugated molecules.
